Breast cancer in pregnancy

Journal of Obstetrics and Gynaecology

Volumn 26, Issue 1, 2006, Pages 1-4

  Eedarapalli, P ^a,c   Jain, S ^b  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c Bishoppdown Farm   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; DOXORUBICIN; EPIRUBICIN; METHOTREXATE; METOCLOPRAMIDE; MORPHINE SULFATE; ONDANSETRON; PACLITAXEL; PARACETAMOL; RADIOISOTOPE; SEROTONIN UPTAKE INHIBITOR; STEROID; TAMOXIFEN;

ASPIRATION BIOPSY; BONE MARROW SUPPRESSION; BREAST CANCER; BREAST FEEDING; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHILDHOOD CANCER; CONGENITAL MALFORMATION; DIAGNOSTIC TEST; DRUG EXCRETION; DRUG METABOLISM; DRUG SAFETY; FEMALE; FETAL HEMORRHAGE; FETAL WELL BEING; FETUS DEATH; GENITAL MALFORMATION; GOLDENHAR SYNDROME; HEMATOLOGIC DISEASE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; MATERNAL TREATMENT; MEDLINE; MENTAL DEFICIENCY; METASTASIS; MICROCEPHALY; PLACENTA DISORDER; PLACENTA INSUFFICIENCY; PREGNANCY DISORDER; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPONTANEOUS ABORTION; STANDARDIZATION; TACHYPNEA; TERATOGENICITY; THERAPY DELAY; THROMBOEMBOLISM; TOXICITY; UTERINE CERVIX CANCER;

BREAST FEEDING; BREAST NEOPLASMS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROGNOSIS; RISK FACTORS;

EID: 30344472399     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610500363808     Document Type: Review

References (20)

1. Aziz S, Pervez S, Khan S, Siddiqui T, Kayani N, Israr M et al. 2003. Case control study of novel prognostic markers and disease in pregnancy/lactation- associated breast carcinoma. Pathology Research and Practice 199:15-21.
2. Barnavon Y, Wallack MK. 1990. Management of the pregnant patient with carcinoma of the breast. Surgical Gynecology and Obstetrics 171:347-352.
3. Barni S, Ardizzoia A, Zanetta G, Strocchi E, Lissoni P, Tancini G. 1992. Weekly doxorubicin chemotherapy for breast cancer in pregnancy - a case report. Tumori 78:349-350.
4. Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE. 1999. Management of breast cancer during pregnancy using a standardised protocol. Journal of Clinical Oncology 17:855-861.
5. Clark RM, Chua T. 1989. Breast cancer and pregnancy: the ultimate challenge. Clinical Oncology 1:11-18.
6. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD. 2001. Breast carcinoma. In: Williams Obstetrics. 21st ed. New York: McGraw-Hill.
7. Gadduci A, Cosio S, Fanucchi A, Nardini V, Roncella M, Conte PF. et al. 2003. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of literature. Anticancer Research 23:5225-5229.
8. Galliard B, Leng JJ, Greller J, Ducint D, Saux MC. 1995. Transplacental passage of epirubicin. Journal of Gynecological and Obstetric Biology Reproduction (Paris) 24:63-68.
9. Guinea VF, Olsson H, Moller T, Hess KR, Taylor SH, Fahey T. 1994. Effect of pregnancy on prognosis for young women with breast cancer. Lancet 343:1587-1589.
10. Hoover HC Jr. 1990. Breast cancer during pregnancy and lactation. Surgical Clinics of North America 70:1151-1163.
11. Jacob JH, Stringer CA. 1990. Diagnosis and management of cancer during pregnancy. Seminars in Perinatology 14:79-87.
12. Kouvaris JR, Antypas CE, Sandilos PH, Plataniotis GA, Tympanides CN, Vlahos LJ. 2000. Postoperative tailored radiotherapy for locally advanced breast carcinoma during pregnancy: a therapeutic dilemma. American Journal of Obstetrics and Gynecology 183:498-499.
13. Kuerer HM, Cunningham JD, Brower ST, Tartter PI. 1997. Breast carcinoma associated with pregnancy and lactation. Surgical Oncology 6:93-98.
14. Lehner R, Strohmer H, Jirecek S, Goharkhay N, Tringler B, Barrada M. 2001. Placental insufficiency and maternal death caused by advanced stage of breast cancer in third trimester. European Journal of Obstetric and Gynecological Reproductive Biology 99:272-273.
15. Meyer-Wittkopf M, Barth H, Emons G, Schmidt S. 2001. Fetal cardiac effects of doxorubicin therapy for carcinoma of breast during pregnancy: case report and review of literature. Ultrasound in obstetrics and Gynecology 18:62-66.
16. Nettleton J, Long J, Kuban D, Wu R, Shaeffer J, El-Mahdi A. 1996. Breast cancer during pregnancy: Quantifying the risk of treatment delay. Obstetrics and Gynecology 87:414.
17. Peto R, Boreham J, Clarke M, Davies C, Beral V. 2000. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 355:1822.
18. Petrek J, Dukoff R, Rogatko A. 1991. Prognosis of pregnancy associated breast cancer. Cancer 67:869-872.
19. Royal College of Obstetricians and Gynaecologists (RCOG). 2004. Pregnancy and breast cancer. Greentop guideline, no. 12. London: Royal College of Obstetricians and Gynaecologists.
20. Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. 1996. Maternal and fetal outcome following breast cancer in pregnancy. In: Koren G, Lishner M, Farine D, editors. Cancer in pregnancy: Maternal and fetal risks. Cambridge: Cambridge University Press. p 95-106.